secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2022-04-28T23:59:59+00:00
Accession:  0001628280-22-011111
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen adopts amended executive severance plan with enhanced CIC and non-CIC benefits
--------------------------------------------------------------------------------

- Plan covers CEO Rocca, CFO Adawi, COO Hazeltine, and CMO Debra Zack.
- Non-CIC termination: cash severance of 50% (75% for CEO) of base salary plus COBRA for 6 (9 for CEO) months.
- CIC termination: cash severance of 100% (125% for CEO) of base salary, COBRA for 12 (15 for CEO) months, and full equity vesting.
- Payments require execution of a general release of claims.
- Plan effective April 25, 2022; supersedes prior severance arrangements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000162828022011111/0001628280-22-011111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000162828022011111/exdx-20220425.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-011111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer